Financial statements Biocent
Balance sheet data of BIOCENT
|
Year
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|
| Total assets | 2 144 073,69 | 4 112 778,72 | 6 554 966,14 | 7 011 005,81 |
| A. Fixed assets | 456 733,11 | 1 810 802,71 | 3 033 378,27 | 3 705 966,66 |
| B. Current assets | 1 687 340,58 | 2 301 976,01 | 3 521 587,87 | 3 305 039,15 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 2 144 073,69 | 4 112 778,72 | 6 554 966,14 | 7 011 005,81 |
| A. Equity | 49 358,02 | 1 542 486,78 | 1 817 916,43 | 1 125 226,98 |
| B. Liabilities and provisions for liabilities | 2 094 715,67 | 2 570 291,94 | 4 737 049,71 | 5 885 778,83 |
| I. Long-term liabilities | 0,00 | 600 000,00 | 1 100 000,00 | 2 280 913,88 |
| II. Short-term liabilities | 1 964 255,67 | 1 970 291,94 | 2 680 494,76 | 3 169 318,83 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.